Jeff E. Knight - Dec 31, 2023 Form 5 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Chief Operating Officer
Signature
/s/ Marc Wilson, as attorney-in-fact
Stock symbol
CRNX
Transactions as of
Dec 31, 2023
Transactions value $
$27,294
Form type
5
Date filed
2/12/2024, 04:32 PM
Previous filing
Mar 17, 2023
Next filing
Mar 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Other $13.3K +891 +2.59% $14.98 35.3K May 22, 2023 Direct F1
transaction CRNX Common Stock Other $13.9K +931 +2.64% $14.98 36.2K Nov 20, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under Crinetics Pharmaceuticals, Inc. 2018 Employee Stock Purchase Plan in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c),